In pancreatic cancer cell line models, HSP27 has been shown to regulate the expression of Snail, E-cadherin, and ERCC1, thereby potentially contributing to the development of resistance to gemcitabine. This evidence concerns the gene HSPB2 and pancreatic neoplasm.